Hagen v. Celotex Corp.

816 S.W.2d 667, 1991 Mo. LEXIS 99, 1991 WL 176326
CourtSupreme Court of Missouri
DecidedSeptember 10, 1991
Docket73520
StatusPublished
Cited by36 cases

This text of 816 S.W.2d 667 (Hagen v. Celotex Corp.) is published on Counsel Stack Legal Research, covering Supreme Court of Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hagen v. Celotex Corp., 816 S.W.2d 667, 1991 Mo. LEXIS 99, 1991 WL 176326 (Mo. 1991).

Opinions

BLACKMAR, Judge.

The husband and children of Gloria Ha-gen seek damages for her death in 1981 from mesothelioma, a rare malignant condition usually associated with exposure to asbestos fibers.1 See generally Stedman’s Medical Dictionary (5th Unabridged Lawyers’ Edition 1982). Her husband, Charles, had been an asbestos worker since the time of their marriage in 1941, and she was constantly exposed to asbestos dust as she washed his coveralls each Saturday. The defendants concede that asbestos exposure was the underlying cause of her illness and death, but argue that the plaintiffs have not established that defendants’ products directly contributed to her disease. Twelve asbestos manufacturers were named as defendants but settlements and bankruptcies [669]*669reduced the number to three by the time of the trial, at which the jury returned a verdict in favor of the plaintiffs for $2,000,-000.2 Following trial defendant Celotex Corporation was excused from the case after seeking Chapter 11 protection, leaving only defendants Fibreboard Corporation and Owens-Illinois, Inc., as appellants. The Court of Appeals, Eastern District, reversed as to Owens-Illinois but affirmed as to Fibreboard, and, as a part of its initial opinion, transferred the case here because of the importance of the question whether the defendants were entitled to an instructional definition of “unreasonably dangerous.” We stand possessed of the entire case, and now reverse and remand for further proceedings, concluding that points other than the one highlighted by the court of appeals are dispositive.

1. Submissibility

a. As to Owens-Illinois

Owens-Illinois was the proprietor of the asbestos-containing insulation product “Kaylo” until April 30, 1958, when it sold its Kaylo division to Owens-Corning Fiberglass. It has not manufactured or distributed any product containing asbestos since then. The parties stipulated that Owens-Illinois was not liable for exposure to Kay-lo occurring after May 1, 1958.

Plaintiff Charles Hagen presented a list showing his various job locations, the time periods during which he worked at each, and the products used at each job. The exhibit contained only one mention of Kay-lo prior to 1958, as follows:

1954, 1959-1971 Lambert Airport Pabco Insulation Johns-Manville 85% Mag Cement Kaylo Webers 48 Eagle-Picher One Cote Cement Keene Super Powerhouse Cement

While the exhibit indicates that Charles Hagen worked with Kaylo at Lambert Airport it does not establish whether this use took place in 1954, when Owens-Illinois manufactured Kaylo, or during the period 1959-1971, when Owens-Corning was the manufacturer.3

In an attempt at clarification counsel for the appellants asked Mr. Hagen several questions on cross-examination about his work at Lambert Airport in 1954. He mentioned five products he used during that time but made no mention of Kaylo. Thus, the only evidence connecting him with Kaylo was the ambiguous reference in the list. The exhibit provides no more than equal support for two inconsistent and contradictory propositions and so is insufficient to sustain the plaintiffs’ burden of establishing either.4 The judgment against Owens-Illinois must be reversed.

b. As to Fibreboard

Asbestos is a mineral product which once was widely used in insulation materials. Over a period of years distressing symptoms appeared in persons who had had substantial exposure to asbestos. Perhaps the most common ailment is asbestosis, which is a nonmalignant scarring of lung tissue. There are also malignant conditions attributable to asbestos exposure, of which mesothelioma is one. Mesothelioma [670]*670is actuated by asbestos fibers which make their way to the pleural cavity.

Asbestos exists in different forms and is used in products in different concentrations and consistencies. The most dangerous is cracidolite, which was not used in Fibre-board’s products. Those products, rather, contained asbestos in the chrysotile and amosite (amoebocyte) forms. Plaintiffs’ experts testified that all asbestos products are dangerous but agreed that the several forms of asbestos have different properties and that crocidolite is the most dangerous.

Charles Hagen testified to having worked with asbestos products of at least nine manufacturers over a period of thirty years. The greater part of his work was with Johns-Manville products; his use of other products is not quantified. Fibre-board argues that the plaintiffs have failed to prove that its products were a substantial causative factor in Mrs. Hagen’s illness.

The plaintiffs, in order to recover against any defendant, must establish that that defendant’s products directly contributed to the death. This requires evidence that the product of each defendant sought to be held liable was a “substantial factor" in causing the harm.5 In a case of this kind the plaintiff must establish the causal relationship by expert testimony. Kircher v. Purina Mills, Inc., 775 S.W.2d 115 (Mo. banc 1989); Missouri Farmers Association v. Kempker, 726 S.W.2d 723 (Mo. banc 1987). Of the plaintiffs’ expert witnesses only the treating internist, Dr. Dew, expressed a competent opinion as to the relationship between asbestos products and Gloria’s death.6 He testified that, to a “reasonable degree of medical certainty,” dust from products containing asbestos directly caused or directly contributed to her cancer and death. He did not identify particular products at this point. He said that the dosage is not particularly significant in causing mesothelioma and that the material circumstance is the fact of exposure.

Fibreboard used the brand name “Pab-co” for its asbestos products. As Dr. Dew concluded his direct examination the following exchange occurred:

Q And in your opinion, is there a difference regarding their causal effect of mesothelioma from one to the other?
A I think there might be some physical difference that most announce that all asbestos can cause problems. As reviewed information, one of the textbooks, Brown’s, for all practical purposes all fibers would be viewed the same. I don’t think there is good evidence that you can extricate from the type of fibers as to the presentation of the cancer. The problem with it is asbestos is not single standing. Asbestos has many substances, so there’s very seldom a pure asbestos anywhere in the products that we have.

At no point was Dr. Dew asked about the peculiar properties of the Pabco products Mr. Hagen used. Nor was his opinion sought as to whether these particular products contributed to the death from meso-thelioma. On cross-examination he testified as follows:

Q In fact, I represent a company called Owens-Illinois, Incorporated, and I also represent Fibreboard. Let me ask you this question. You can’t sit here and tell us today that Owens-Illinois’ fibers hit the pleura and caused the mesothelio-ma?
A I cannot.
Q And I could ask you the same question about Fibreboard, and your answer would be the same?
A Right.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Headley v. State of Missouri
E.D. Missouri, 2025
Constantine, K. v. Lenox Instr. Co.
2024 Pa. Super. 216 (Superior Court of Pennsylvania, 2024)
Coonce v. Simons
520 S.W.3d 821 (Missouri Court of Appeals, 2017)
Poage v. Crane Co.
523 S.W.3d 496 (Missouri Court of Appeals, 2017)
Urbach v. Okonite Co.
514 S.W.3d 653 (Missouri Court of Appeals, 2017)
Thomas v. McKeever's Enterprises, Inc.
388 S.W.3d 206 (Missouri Court of Appeals, 2012)
Wagner v. Bondex International, Inc.
368 S.W.3d 340 (Missouri Court of Appeals, 2012)
Sanders v. Ahmed
364 S.W.3d 195 (Supreme Court of Missouri, 2012)
Barker v. Schisler
329 S.W.3d 726 (Missouri Court of Appeals, 2011)
Strong v. American Cyanamid Co.
261 S.W.3d 493 (Missouri Court of Appeals, 2008)
St. Anthony's Medical Center v. Metze
23 S.W.3d 692 (Missouri Court of Appeals, 2000)
Dorman v. Bridgestone/Firestone, Inc.
992 S.W.2d 231 (Missouri Court of Appeals, 1999)
Newman v. Ford Motor Co.
975 S.W.2d 147 (Supreme Court of Missouri, 1998)
Howard v. State
966 S.W.2d 821 (Court of Appeals of Texas, 1998)
Nugent v. Owens-Corning Fiberglas, Inc.
925 S.W.2d 925 (Missouri Court of Appeals, 1996)
Kraus v. Celotex Corp.
925 F. Supp. 646 (E.D. Missouri, 1996)
Anderson v. F.J. Little Machine Co.
68 F.3d 1113 (Eighth Circuit, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
816 S.W.2d 667, 1991 Mo. LEXIS 99, 1991 WL 176326, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hagen-v-celotex-corp-mo-1991.